Ads
related to: MRNA Stock- Bull & Bear 3X ETFs
Fixed Income, International Equity
Market Cap And Sector Equity
- ETF Line-up
View Direxion's Complete List of
Leveraged and Inverse ETFs.
- ETF Education
View Our Educational Library to
Learn More About Our Products.
- Education
Articles, videos & tools to help
understand Leveraged ETFs and more.
- Bull & Bear 3X ETFs
invesco.com has been visited by 1M+ users in the past month
Search results
Unveiling Moderna (MRNA)'s Value: Is It Really Priced Right? A C
Guru Focus· 1 day agoModerna Inc (MRNA, Financial) recently experienced a significant daily loss of 7.74%, yet it boasts a 3-month gain of 72.72%. This analysis aims to explore Moderna's valuation ...
Nasdaq Tops 17K: 5 Best-Performing Stocks in ETF YTD
Zacks via Yahoo Finance· 4 hours agoThe Nasdaq Composite Index topped the 17,000 level for the first time. We have highlighted five best-performing stocks of QQQ this year that led the way...
Vaccine stocks gain, Moderna and Pfizer in talks with the US on bird flu vaccines By Investing.com
Investing.com· 6 days agoVaccine stocks gain, Moderna and Pfizer in talks with the US on bird flu vaccines
...Scoops Up Shares Of AMD And Palantir — Dumps Moderna Stock Worth $4.4M - ARK Genomic Revolution...
Benzinga· 15 hours agoThese trades reflect Ark’s strategic adjustments amidst market movements. The AMD Trade ...Internet...
The Next Humira? Insmed Catapults 119% On Its 'Very Attractive' Opportunity In Lung Disease.
Investor's Business Daily· 23 hours agoPatients with cystic fibrosis have mutations in their...CFTR gene. Arcturus uses an inhaled drug to...
Cathie Wood's ARK buys AMD, sells Moderna in latest stock trades By Investing.com
Investing.com· 19 hours agoCathie Wood's ARK buys AMD, sells Moderna in latest stock trades
Moderna Inc [NASDAQ: MRNA] Sees Increase in Stock Value – Knox Daily
Knox Daily· 5 days agoGenuity has initiated its “Hold” rating for MRNA. Earlier on November 03, 2023, HSBC Securities upgraded its rating. Their new recommendation was “a Hold” for MRNA ...
Should You Buy This Stock After a Regulatory Setback?
Motley Fool via Yahoo Finance· 3 days agoThe past two-and-a-half years have been rough for Moderna (NASDAQ: MRNA). Though the biotech was...
Why Vaccine Stocks Rallied This Week
Motley Fool via Yahoo Finance· 5 days agoWhile avian flu could potentially mutate into a human-transmissible disease, it appears the stock moves across these vaccine developers this week may be...
... Performing Large-Cap Stocks Last Week (May 20-May 26, 2024): Are They In Your Portfolio? -...
Benzinga· 3 days agoAre they in your portfolio? First Solar, Inc. FSLR shares jumped 41.5% possibly in response to...
